Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors, IV. Synthesis and biological activity of the metabolites of 6-[4-(1-cyclohexyl-1H-5-tetrazolyl)butoxy]-2-oxo-1,2,3,4- tetrahydroquinoline (OPC-13013).
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001393:Azoles / Q000138:chemical synthesis*; D000077407:Cilostazol; D003094:Collagen / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D011817:Rabbits; D013329:Structure-Activity Relationship; D013777:Tetrazoles / Q000138:chemical synthesis* / Q000494:pharmacology
D001393:Azoles; D013777:Tetrazoles; D000244:Adenosine Diphosphate; D003094:Collagen; D000077407:Cilostazol